These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1579545)

  • 21. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A; Mitchelson F
    Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M; Hattori Y; Gando S; Kanno M
    J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
    Musílková J; Tucek S
    Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C14-aminosteroid LNF 209, an agent with positive inotropic and antimuscarinic activity.
    Lüllmann H; Mohr K
    J Cardiovasc Pharmacol; 1992; 20(5):807-12. PubMed ID: 1280745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I; Porta S; Schauenstein K
    Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
    Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
    J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
    Tränkle C; Kostenis E; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between methylene blue and the cholinergic system.
    Pfaffendorf M; Bruning TA; Batnik HD; van Zwieten PA
    Br J Pharmacol; 1997 Sep; 122(1):95-8. PubMed ID: 9298533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.
    Lüllmann H; Mohr K; Pfeffer J
    J Pharmacol Exp Ther; 1988 Nov; 247(2):710-4. PubMed ID: 3183965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.
    Uemura H; Hara Y; Endou M; Mori K; Nakaya H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):73-9. PubMed ID: 8750919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J; Wang SZ; Forray C; el-Fakahany EE
    Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of muscarinic acetylcholine receptors in cultured guinea pig pancreatic acini.
    Hootman SR; Brown ME; Williams JA; Logsdon CD
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G75-83. PubMed ID: 2425639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
    Giraldo E; Viganò MA; Hammer R; Ladinsky H
    Mol Pharmacol; 1988 Jun; 33(6):617-25. PubMed ID: 3380078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of edrophonium with muscarinic acetylcholine M2 and M3 receptors.
    Tanito Y; Miwa T; Endou M; Hirose Y; Gamoh M; Nakaya H; Okumura F
    Anesthesiology; 2001 May; 94(5):804-14. PubMed ID: 11388532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.